TreeWAS – Variant ID: rs9316500

Hospitalization Episode Statistics (HES)

Self-Reported Statistics (SRS)

Hierarchical visualisation How to interpret this figure?

Click here to show this figure without filtering.

Click on a node to zoom (except terminal nodes).

Download this figure in format

Results table

Term	Risk posterior probability	No effect posterior probability	Protective posterior probability
E11 Non-insulin-dependent diabetes mellitus	0.000	0.022	0.978
E10-E14 Diabetes mellitus	0.000	0.025	0.975
E10 Insulin-dependent diabetes mellitus	0.000	0.025	0.975
E11.9 Without complications	0.000	0.036	0.964
E10.9 Without complications	0.000	0.069	0.931
E10.4 With neurological complications	0.000	0.074	0.926
E11.3 With ophthalmic complications	0.000	0.082	0.918
E10.5 With peripheral circulatory complications	0.000	0.109	0.891
E11.5 With peripheral circulatory complications	0.000	0.112	0.888
E11.6 With other specified complications	0.000	0.121	0.879
E11.2 With renal complications	0.000	0.153	0.847
E14 Unspecified diabetes mellitus	0.000	0.163	0.837
E10.2 With renal complications	0.000	0.200	0.800
E11.8 With unspecified complications	0.000	0.222	0.778
E10.6 With other specified complications	0.000	0.226	0.774
E10.3 With ophthalmic complications	0.000	0.257	0.743
E10.1 With ketoacidosis	0.000	0.269	0.731
E13 Other specified diabetes mellitus	0.000	0.292	0.708
E10.8 With unspecified complications	0.000	0.298	0.702
E11.7 With multiple complications	0.000	0.299	0.701
E12 Malnutrition-related diabetes mellitus	0.000	0.301	0.699
E10.7 With multiple complications	0.000	0.301	0.699
E14.6 With other specified complications	0.000	0.303	0.697
E14.2 Withrenal complications	0.000	0.336	0.664
E11.4 With neurological complications	0.000	0.338	0.662
E11.0 With coma	0.000	0.342	0.658
E10.0 With coma	0.000	0.343	0.657
E14.4 With neurological complications	0.000	0.347	0.653
E14.3 With ophthalmic complications	0.000	0.350	0.650
E14.8 With unspecified complications	0.000	0.396	0.604
E14.7 With multiple complications	0.000	0.400	0.600
E14.0 With coma	0.000	0.400	0.600
E14.5 With peripheral circulatory complications	0.000	0.425	0.575
E14.9 Without complications	0.000	0.440	0.560
E14.1 With ketoacidosis	0.000	0.458	0.542
E13.9 Without complications	0.000	0.484	0.516
E13.8 With unspecified complications	0.000	0.492	0.507
E13.7 With multiple complications	0.000	0.492	0.507
E13.6 With other specified complications	0.000	0.492	0.507
E13.5 With peripheral circulatory complications	0.000	0.492	0.507
E13.4 With neurological complications	0.000	0.492	0.507
E13.3 With ophthalmic complications	0.000	0.492	0.507
E13.2 With renal complications	0.000	0.492	0.507
E13.1 With ketoacidosis	0.000	0.492	0.507
E13.0 With coma	0.000	0.492	0.507
E12.9 Without complications	0.000	0.498	0.501
E12.8 With unspecified complications	0.000	0.498	0.501
E12.7 With multiple complications	0.000	0.498	0.501
E12.6 With other specified complications	0.000	0.498	0.501
E12.5 With peripheral circulatory complications	0.000	0.498	0.501
E12.4 With neurological complications	0.000	0.498	0.501
E12.3 With ophthalmic complications	0.000	0.498	0.501
E12.2 With renal complications	0.000	0.498	0.501
E12.1 With ketoacidosis	0.000	0.498	0.501
E12.0 With coma	0.000	0.498	0.501
E11.1 With ketoacidosis	0.000	0.501	0.499
C82.9 Follicular non-Hodgkin's lymphoma, unspecified	0.000	0.920	0.080
T43 Poisoning by psychotropic drugs, not elsewhere classified	0.073	0.927	0.000
T43.3 Phenothiazine antipsychotics and neuroleptics	0.070	0.930	0.000
T36-T50 Poisoning by drugs, medicaments and biological substances	0.070	0.930	0.000
T39 Poisoning by nonopioid analgesics, antipyretics and antirheumatics	0.066	0.934	0.000
T44 Poisoning by drugs primarily affecting the autonomic nervous system	0.065	0.935	0.000
T46 Poisoning by agents primarily affecting the cardiovascular system	0.063	0.937	0.000
T39.0 Salicylates	0.062	0.938	0.000
T47 Poisoning by agents primarily affecting gastro-intestinal system	0.062	0.938	0.000
T43.4 Butyrophenone and thioxanthene neuroleptics	0.061	0.938	0.000
T44.7 Beta-Adrenoreceeptor antagonists, not elsewhere classified	0.060	0.940	0.000
T43.6 Psychostimulants with abuse potential	0.060	0.940	0.000
T43.5 Other and unspecified antipsychotics and neuroleptics	0.060	0.940	0.000
T43.2 Other and unspecified antidepressants	0.057	0.943	0.000
T43.1 Monoamine-oxidase-inhibitor antidepressants	0.056	0.944	0.000
T40 Poisoning by narcotics and psychodysleptics [hallucinogens]	0.056	0.944	0.000
T48 Poisoning by agents primarily acting on smooth and skeletal muscles and the respiratory system	0.054	0.946	0.000
T37 Poisoning by other systemic anti-infectives and antiparasitics	0.053	0.947	0.000
T47.0 Histamine H(2)-receptor antagonists	0.053	0.947	0.000
T43.9 Psychotropic drug, unspecified	0.053	0.947	0.000
T43.8 Other psychotropic drugs, not elsewhere classified	0.053	0.947	0.000
T47.6 Antidiarrhoeal drugs	0.053	0.947	0.000
T46.3 Coronary vasodilators, not elsewhere classified	0.053	0.947	0.000
T39.8 Other nonopioid analgesics and antipyretics, not elsewhere classified	0.052	0.948	0.000
T44.9 Other and unspecified drugs primarily affecting the nervous system	0.051	0.948	0.000
C82 Follicular [nodular] non-Hodgkin's lymphoma	0.000	0.949	0.051
T46.6 Antihyperlipidaemic and antiarteriosclerotic drugs	0.051	0.949	0.000
T39.3 Other nonsteroidal anti-inflammatory drugs [NSAID]	0.051	0.949	0.000
T49 Poisoning by topical agents primarily affecting skin and mucous membrane and by ophthalmological, otorhinolarygological and dental drugs	0.051	0.949	0.000
T41 Poisoning by anaesthetics and therapeutic gases	0.051	0.949	0.000
T36 Poisoning by systemic antibiotics	0.050	0.950	0.000
T43.0 Tricyclic and tetracyclic antidepressants	0.048	0.952	0.000
T44.3 Other parasympatholytics [anticholinergics and antimuscarines] and spasmolytics, not elsewhere classified	0.048	0.952	0.000
T46.5 Other antihypertensive drugs, not elsewhere classified	0.048	0.952	0.000
T40.4 Other synthetic narcotics	0.048	0.952	0.000
T39.4 Antirheumatics, not elsewhere classified	0.047	0.953	0.000
T39.2 Pyrazolone derivatives	0.047	0.953	0.000
T46.0 Cardiac-stimulant glycosides and drugs of similar action	0.047	0.953	0.000
T44.8 Centrally acting and afrenergic-neuron-blocking agents, not elsewhere classified	0.047	0.953	0.000
T44.5 Predominantly Beta-adrenoreceptor agonists, not elsewhere classified	0.047	0.953	0.000
T44.4 Predominantly Alpha-adrenoreceptor agonists, not elsewhere classified	0.047	0.953	0.000
T44.2 Ganglionic blocking drugs, not elsewhere classified	0.047	0.953	0.000
T44.1 Other parasympathomimetics [cholinergics]	0.047	0.953	0.000
T44.0 Anticholinesterase agents	0.047	0.953	0.000
T46.1 Calcium-channel blockers	0.047	0.953	0.000
T45 Poisoning by primarily systemic and haematological agents, not elsewhere classified	0.047	0.953	0.000
T44.6 Alpha-Adrenoreceeptor antagonists, not elsewhere classified	0.046	0.953	0.000
T39.1 4-Aminophenol derivatives	0.046	0.954	0.000
T46.9 Other and unspecified agents primarily affecting the cardiovascular system	0.045	0.955	0.000
T46.8 Antivaricose drugs, including sclerosing agents	0.045	0.955	0.000
T46.7 Peripheral vasodilators	0.045	0.955	0.000
T46.2 Other antidysrhythmic drugs, not elsewhere classified	0.045	0.955	0.000
T38 Poisoning by hormones and their synthetic substitutes and antagonists, not elsewhere classified	0.045	0.955	0.000
T47.9 Agent primarily affecting the gastro-intestinal system, unspecified	0.045	0.955	0.000
T47.8 Other agents primarily affecting the gastro-intestinal system	0.045	0.955	0.000
T47.7 Emetics	0.045	0.955	0.000
T47.5 Digestants	0.045	0.955	0.000
T47.4 Other laxatives	0.045	0.955	0.000
T47.3 Saline and osmotic laxatives	0.045	0.955	0.000
T47.2 Stimulant laxatives	0.045	0.955	0.000
C82.7 Other types of follicular non-Hodgkin's lymphoma	0.000	0.956	0.044
T46.4 Angiotensin-converting-enzyme inhibitors	0.043	0.957	0.000
T48.5 Anti-common-cold drugs	0.043	0.957	0.000
T50 Poisoning by diuretics and other and unspecified drugs, medicaments and biological substances	0.042	0.958	0.000
T37.8 Other specified systemic anti-infectives and antiparasitics	0.041	0.959	0.000
T47.1 Other antacids and anti-gastric-secretion drugs	0.041	0.959	0.000
C82.1 Mixed small cleaved and large cell, follicular	0.000	0.960	0.040
T39.9 Nonopioid analgesic, antipyretic and antirheumatic, unspecified	0.040	0.960	0.000
T40.9 Other and unspecified psychodysleptics [hallucinogens]	0.040	0.960	0.000
T40.8 Lysergide [LSD]	0.040	0.960	0.000
T40.7 Cannabis (derivatives)	0.040	0.960	0.000
T40.3 Methadone	0.040	0.960	0.000
T40.1 Heroin	0.040	0.960	0.000
T40.0 Opium	0.040	0.960	0.000
T36.8 Other systemic antibiotics	0.039	0.960	0.000
T40.5 Cocaine	0.039	0.961	0.000
T40.2 Other opioids	0.039	0.961	0.000
T48.7 Other and unspecified agents primarily acting on the respiratory system	0.039	0.961	0.000
T48.6 Antiasthmatics, not elsewhere classified	0.039	0.961	0.000
T48.4 Expectorants	0.039	0.961	0.000
T48.3 Antitussives	0.039	0.961	0.000
T48.2 Other and unspecified agents primarily acting on muscles	0.039	0.961	0.000
T48.1 Skeletal muscle relaxants [neuromuscular blocking agents]	0.039	0.961	0.000
T48.0 Oxytocic drugs	0.039	0.961	0.000
C82.0 Small cleaved cell, follicular	0.000	0.961	0.039
T37.9 Systemic anti-infective and antiparasitic, unspecified	0.038	0.961	0.000
T37.5 Antiviral drugs	0.038	0.961	0.000
T37.4 Anthelminthics	0.038	0.961	0.000
T37.3 Other antiprotozoal drugs	0.038	0.961	0.000
T37.2 Antimalarials and drugs acting on other blood protozoa	0.038	0.961	0.000
T37.1 Antimycobacterial drugs	0.038	0.961	0.000
T37.0 Sulphonamides	0.038	0.961	0.000
T40.6 Other and unspecified narcotics	0.037	0.962	0.000
Chapter IV Endocrine, nutritional and metabolic diseases	0.000	0.963	0.037
C82.6 Cutaneous follicle centre lymphoma	0.000	0.963	0.037
C82.5 Diffuse follicle centre lymphoma	0.000	0.963	0.037
T41.5 Therapeutic gases	0.036	0.963	0.000
T41.4 Anaesthetic, unspecified	0.036	0.963	0.000
T41.3 Local anaesthetics	0.036	0.963	0.000
T41.2 Other and unspecified general anaesthetics	0.036	0.963	0.000
T41.1 Intravenous anaesthetics	0.036	0.963	0.000
T41.0 Inhaled anaesthetics	0.036	0.963	0.000
T49.9 Topical agent, unspecified	0.036	0.963	0.000
T49.8 Other topical agents	0.036	0.963	0.000
T49.7 Dental drugs, topically applied	0.036	0.963	0.000
T49.6 Otorhinolaryngological drugs and preparations	0.036	0.963	0.000
T49.5 Ophthalmological drugs and preparations	0.036	0.963	0.000
T49.4 Keratolytics, keratoplastics and other hair treatment drugs and preparations	0.036	0.963	0.000
T49.3 Emollients, demulcents and protectants	0.036	0.963	0.000
T49.2 Local astringents and local detergents	0.036	0.963	0.000
T49.1 Antipruritics	0.036	0.963	0.000
T49.0 Local antifungal, anti-infective and anti-inflammatory drugs, not elsewhere classified	0.036	0.963	0.000
C82.3 Follicular lymphoma grade IIIa	0.000	0.963	0.036
C82.2 Large cell, follicular	0.000	0.964	0.036
T36.9 Systemic antibiotic, unspecified	0.036	0.964	0.000
T36.7 Antifungal antibiotics, systemically used	0.036	0.964	0.000
T36.6 Rifamycins	0.036	0.964	0.000
T36.5 Aminoglycosides	0.036	0.964	0.000
T36.4 Tetracyclines	0.036	0.964	0.000
T36.3 Macrolides	0.036	0.964	0.000
T36.2 Chloramphenicol group	0.036	0.964	0.000
T36.1 Cefalosporins and other Beta-lactam antibiotics	0.036	0.964	0.000
T45.2 Vitamins, not elsewhere classified	0.035	0.964	0.000
T45.9 Primarily systemic and haematological agent, unspecified	0.034	0.966	0.000
T45.8 Other primarily systemic and haematological agents	0.034	0.966	0.000
T45.7 Anticoagulant antagonists, vitamin K and other coagulants	0.034	0.966	0.000
T45.6 Fibrinolysis-affecting drugs	0.034	0.966	0.000
T45.4 Iron and its compounds	0.034	0.966	0.000
T45.3 Enzymes, not elsewhere classified	0.034	0.966	0.000
E15-E16 Other disorders of glucose regulation and pancreatic internal secretion	0.000	0.966	0.034
E40-E46 Malnutrition	0.000	0.967	0.033
T38.6 Antigonadotrophins. antioestrogens, antiandrogens, not elsewhere classified	0.033	0.967	0.000
C82.4 Follicular lymphoma grade IIIb	0.000	0.967	0.033
T45.0 Antiallergic and antiemetic drugs	0.033	0.967	0.000
T45.5 Anticoagulants	0.033	0.967	0.000
T38.9 Other and unspecified hormone antagonists	0.032	0.968	0.000
T38.7 Androgens and anabolic congeners	0.032	0.968	0.000
T38.5 Other oestrogens and progestogens	0.032	0.968	0.000
T38.4 Oral contraceptives	0.032	0.968	0.000
T38.2 Antithyroid drugs	0.032	0.968	0.000
T38.0 Glucocorticoids and synthetic analogues	0.032	0.968	0.000
T38.8 Other and unspecified hormones and their synthetic substitutes	0.032	0.968	0.000
T50.4 Drugs affecting uric acid metabolism	0.032	0.968	0.000
T50.8 Diagnostic agents	0.032	0.968	0.000
E16 Other disorders of pancreatic internal secretion	0.000	0.969	0.031
R60.0 Localised oedema	0.000	0.969	0.031
T50.7 Analeptics and opioid receptor antagonists	0.031	0.969	0.000
T50.6 Antidotes and chelating agents, not elsewhere classified	0.031	0.969	0.000
T50.5 Appetite depressants	0.031	0.969	0.000
T50.3 Electrolytic, caloric and water-balance agents	0.031	0.969	0.000
T50.1 Loop [high-ceiling] diuretics	0.031	0.969	0.000
T50.0 Mineralocorticoids and their antagonists	0.031	0.969	0.000
E16.2 Hypoglycaemia, unspecified	0.000	0.970	0.030
T45.1 Antineoplastic and immunosuppressive drugs	0.030	0.970	0.000
T38.1 Thyroid hormones and substitutes	0.030	0.970	0.000
E46 Unspecified protein-energy malnutrition	0.000	0.970	0.030
T36.0 Penicillins	0.030	0.970	0.000
T38.3 Insulin and oral hypoglycaemic [antidiabetic] drugs	0.029	0.971	0.000
T50.2 Carbonic-anhydrase inhibitors, benzothiadiazides and other diuretics	0.028	0.971	0.000
E15 Nondiabetic hypoglycaemic coma	0.000	0.976	0.024
A41.5 Septicaemia due to other Gram-negative organisms	0.000	0.976	0.024
E44 Protein-energy malnutrition of moderate and mild degree	0.000	0.976	0.024
E45 Retarded development following protein-energy malnutrition	0.000	0.976	0.024
E43 Unspecified severe protein-energy malnutrition	0.000	0.976	0.024
E42 Marasmic kwashiorkor	0.000	0.976	0.024
E41 Nutritional marasmus	0.000	0.976	0.024
E40 Kwashiorkor	0.000	0.976	0.024
E65-E68 Obesity and other hyperalimentation	0.001	0.976	0.022
E16.0 Drug-induced hypoglycaemia without coma	0.000	0.977	0.023
E16.9 Disorder of pancreatic internal secretion, unspecified	0.000	0.977	0.022
E16.8 Other specified disorders of pancreatic internal secretion	0.000	0.977	0.022
E16.4 Abnormal secretion of gastrin	0.000	0.977	0.022
E16.3 Increased secretion of glucagon	0.000	0.977	0.022
T42 Poisoning by antiepileptic, sedative-hypnotic and anti-Parkinsonism drugs	0.022	0.978	0.000
T50.9 Other and unspecified drugs, medicaments and biological substances	0.021	0.979	0.000
J18.1 Lobar pneumonia, unspecified	0.000	0.979	0.021
E65 Localised adiposity	0.001	0.980	0.019
E16.1 Other hypoglycaemia	0.000	0.980	0.019
K42.9 Umbilical hernia without obstruction or gangrene	0.000	0.982	0.018
E44.1 Mild protein-energy malnutrition	0.000	0.983	0.017
E44.0 Moderate protein-energy malnutrition	0.000	0.983	0.017
T42.8 Anti-Parkinsonism drugs and other central muscle-tone depressants	0.017	0.983	0.000
E67 Other hyperalimentation	0.001	0.983	0.016
E68 Sequelae of hyperalimentation	0.001	0.983	0.016
T42.5 Mixed antiepileptics, not elsewhere classified	0.016	0.984	0.000
T42.3 Barbiturates	0.016	0.984	0.000
T42.2 Succinimides and oxazolidinediones	0.016	0.984	0.000
A49.8 Other bacterial infections of unspecified site	0.000	0.984	0.016
T42.0 Hydantoin derivatives	0.015	0.984	0.000
T42.7 Antiepileptic and sedative-hypnotic drugs, unspecified	0.015	0.984	0.000
J18.0 Bronchopneumonia, unspecified	0.000	0.985	0.015
T42.1 Iminostilbenes	0.015	0.985	0.000
J18 Pneumonia, organism unspecified	0.000	0.985	0.015
E50-E64 Other nutritional deficiencies	0.000	0.985	0.015
A49.1 Streptococcal infection, unspecified	0.000	0.986	0.014
A49 Bacterial infection of unspecified site	0.000	0.986	0.014
K58.0 Irritable bowel syndrome with diarrhoea	0.000	0.986	0.014
C90 Multiple myeloma and malignant plasma cell neoplasms	0.000	0.986	0.014
Z80.3 Family history of malignant neoplasm of breast	0.000	0.986	0.014
K42 Umbilical hernia	0.000	0.986	0.014
C90.0 Multiple myeloma	0.000	0.987	0.013
T42.6 Other antiepileptic and sedative-hypnotic drugs	0.013	0.987	0.000
C81-C96 Malignant neoplasms, stated or presumed to be primary, of lymphoid, haematopoietic and related tissue	0.000	0.987	0.013
E67.8 Other specified hyperalimentation	0.001	0.987	0.012
E67.3 Hypervitaminosis D	0.001	0.987	0.012
E67.2 Megavitamin-B6 syndrome	0.001	0.987	0.012
E67.1 Hypercarotenaemia	0.001	0.987	0.012
E67.0 Hypervitaminosis A	0.001	0.987	0.012
Z75.1 Person awaiting admission to adequate facility elsewhere	0.012	0.988	0.000
C90.2 Plasmacytoma, extramedullary	0.000	0.988	0.012
K42.0 Umbilical hernia with obstruction, without gangrene	0.000	0.988	0.012
N40 Hyperplasia of prostate	0.000	0.988	0.012
C90.3 Solitary plasmacytoma	0.000	0.989	0.011
A49.0 Staphylococcal infection, unspecified	0.000	0.989	0.011
E58 Dietary calcium deficiency	0.000	0.989	0.011
A49.2 Haemophilus influenzae infection, unspecified	0.000	0.989	0.011
J18.2 Hypostatic pneumonia, unspecified	0.000	0.989	0.011
E64 Sequelae of malnutrition and other nutritional deficiencies	0.000	0.989	0.011
E63 Other nutritional deficiencies	0.000	0.989	0.011
E56 Other vitamin deficiencies	0.000	0.989	0.011
E50 Vitamin A deficiency	0.000	0.989	0.011
E60 Dietary zinc deficiency	0.000	0.989	0.011
E59 Dietary selenium deficiency	0.000	0.989	0.011
E52 Niacin deficiency [pellagra]	0.000	0.989	0.011
E55 Vitamin D deficiency	0.000	0.989	0.011
C90.1 Plasma cell leukaemia	0.000	0.990	0.010
C91 Lymphoid leukaemia	0.000	0.990	0.010
C81 Hodgkin's disease	0.000	0.990	0.010
A49.3 Mycoplasma infection, unspecified	0.000	0.990	0.010
C93 Monocytic leukaemia	0.000	0.990	0.010
K42.1 Umbilical hernia with gangrene	0.000	0.990	0.010
E54 Ascorbic acid deficiency	0.000	0.990	0.010
M65.96 Synovitis and tenosynovitis, unspecified (Lower leg)	0.010	0.990	0.000
E61 Deficiency of other nutrient elements	0.000	0.990	0.009
C96 Other and unspecified malignant neoplasms of lymphoid, haematopoietic and related tissue	0.000	0.991	0.009
C94 Other leukaemias of specified cell type	0.000	0.991	0.009
A41 Other septicaemia	0.000	0.991	0.009
E51 Thiamine deficiency	0.000	0.991	0.009
J18.9 Pneumonia, unspecified	0.000	0.991	0.009
E20-E35 Disorders of other endocrine glands	0.000	0.991	0.009
E21.3 Hyperparathyroidism, unspecified	0.000	0.991	0.009
M25.51 Pain in joint (Shoulder region)	0.000	0.991	0.009
C81.0 Lymphocytic predominance	0.000	0.991	0.009
C86 Other specified types of T/NK-cell lymphoma	0.000	0.991	0.009
C91.1 Chronic lymphocytic leukaemia	0.000	0.991	0.009
C88 Malignant immunoproliferative diseases	0.000	0.991	0.008
A30-A49 Other bacterial diseases	0.000	0.992	0.008
E21 Hyperparathyroidism and other disorders of parathyroid gland	0.000	0.992	0.008
C81.2 Mixed cellularity	0.000	0.992	0.008
J18.8 Other pneumonia, organism unspecified	0.000	0.992	0.008
C93.1 Chronic monocytic leukaemia	0.000	0.992	0.008
C81.1 Nodular sclerosis	0.000	0.992	0.008
K86.3 Pseudocyst of pancreas	0.000	0.992	0.008
E34.9 Endocrine disorder, unspecified	0.000	0.992	0.008
E50.9 Vitamin A deficiency, unspecified	0.000	0.992	0.008
E50.8 Other manifestations of vitamin A deficiency	0.000	0.992	0.008
E50.7 Other ocular manifestations of vitamin A deficiency	0.000	0.992	0.008
E50.6 Vitamin A deficiency with xerophthalmic scars of cornea	0.000	0.992	0.008
E50.5 Vitamin A deficiency with night blindness	0.000	0.992	0.008
E50.4 Vitamin A deficiency with keratomalacia	0.000	0.992	0.008
E50.3 Vitamin A deficiency with corneal ulceration and xerosis	0.000	0.992	0.008
E50.2 Vitamin A deficiency with corneal xerosis	0.000	0.992	0.008
E50.1 Vitamin A deficiency with Bitot's spot and conjunctival xerosis	0.000	0.992	0.008
E50.0 Vitamin A deficiency with conjunctival xerosis	0.000	0.992	0.008
E56.9 Vitamin deficiency, unspecified	0.000	0.992	0.008
E56.8 Deficiency of other vitamins	0.000	0.992	0.008
E56.1 Deficiency of vitamin K	0.000	0.992	0.008
E56.0 Deficiency of vitamin E	0.000	0.992	0.008
E63.9 Nutritional deficiency, unspecified	0.000	0.992	0.008
E63.8 Other specified nutritional deficiencies	0.000	0.992	0.008
E63.1 Imbalance of constituents of food intake	0.000	0.992	0.008
E63.0 Essential fatty acid [EFA] deficiency	0.000	0.992	0.008
E64.9 Sequelae of unspecified nutritional deficiency	0.000	0.992	0.008
E64.8 Sequelae of other nutritional deficiencies	0.000	0.992	0.008
E64.3 Sequelae of rickets	0.000	0.992	0.008
E64.2 Sequelae of vitamin C deficiency	0.000	0.992	0.008
E64.1 Sequelae of vitamin A deficiency	0.000	0.992	0.008
E64.0 Sequelae of protein-energy malnutrition	0.000	0.992	0.008
C50.9 Breast, unspecified	0.000	0.992	0.008
C91.9 Lymphoid leukaemia, unspecified	0.000	0.992	0.008
E55.0 Rickets, active	0.000	0.992	0.008
C95 Leukaemia of unspecified cell type	0.000	0.992	0.008
E34 Other endocrine disorders	0.000	0.992	0.008
C91.4 Hairy-cell leukaemia	0.000	0.992	0.008
C91.8 Mature B-cell leukaemia Burkitt-type	0.000	0.992	0.008
C91.7 Other lymphoid leukaemia	0.000	0.992	0.008
C91.6 Prolymphocytic leukaemia of T-cell type	0.000	0.992	0.008
C91.5 Adult T-cell leukaemia	0.000	0.992	0.008
C91.3 Prolymphocytic leukaemia	0.000	0.992	0.008
C91.2 Subacute lymphocytic leukaemia	0.000	0.992	0.008
C92 Myeloid leukaemia	0.000	0.992	0.008
C81.4 Lymphocyte-rich classical Hodgkin lymphoma	0.000	0.992	0.008
C81.3 Lymphocytic depletion	0.000	0.992	0.008
K40.9 Unilateral or unspecified inguinal hernia, without obstruction or gangrene	0.000	0.992	0.008
C91.0 Acute lymphoblastic leukaemia	0.000	0.992	0.008
E55.9 Vitamin D deficiency, unspecified	0.000	0.992	0.008
S66.1 Injury of flexor muscle and tendon of other finger at wrist and hand level	0.008	0.992	0.000
C93.9 Monocytic leukaemia, unspecified	0.000	0.992	0.007
C93.7 Other monocytic leukaemia	0.000	0.992	0.007
C93.3 Juvenile myelomonocytic leukaemia	0.000	0.992	0.007
C93.2 Subacute monocytic leukaemia	0.000	0.992	0.007
C93.0 Acute monocytic leukaemia	0.000	0.992	0.007
E53 Deficiency of other B group vitamins	0.000	0.993	0.007
A40 Streptococcal septicaemia	0.000	0.993	0.007
C81.7 Other Hodgkin's disease	0.000	0.993	0.007
E21.1 Secondary hyperparathyroidism, not elsewhere classified	0.000	0.993	0.007
E61.9 Deficiency of nutrient element, unspecified	0.000	0.993	0.007
E61.8 Deficiency of other specified nutrient elements	0.000	0.993	0.007
E61.7 Deficiency of multiple nutrient elements	0.000	0.993	0.007
E61.6 Vanadium deficiency	0.000	0.993	0.007
E61.5 Molybdenum deficiency	0.000	0.993	0.007
E61.4 Chromium deficiency	0.000	0.993	0.007
E61.3 Manganese deficiency	0.000	0.993	0.007
E61.0 Copper deficiency	0.000	0.993	0.007
E24 Cushing's syndrome	0.000	0.993	0.007
A41.4 Septicaemia due to anaerobes	0.000	0.993	0.007
A41.3 Septicaemia due to Haemophilus influenzae	0.000	0.993	0.007
C94.7 Other specified leukaemias	0.000	0.993	0.007
C94.6 Myelodysplastic and myeloproliferative disease, not elsewhere classified	0.000	0.993	0.007
C94.5 Acute myelofibrosis	0.000	0.993	0.007
C94.4 Acute panmyelosis	0.000	0.993	0.007
C94.3 Mast cell leukaemia	0.000	0.993	0.007
C94.2 Acute megakaryoblastic leukaemia	0.000	0.993	0.007
C94.1 Chronic erythraemia	0.000	0.993	0.007
C94.0 Acute erythraemia and erythroleukaemia	0.000	0.993	0.007
C96.9 Malignant neoplasms of lymphoid, haematopoietic and related tissue, unspecified	0.000	0.993	0.007
C96.8 Histiocytic sarcoma	0.000	0.993	0.007
C96.7 Other specified malignant neoplasms of lymphoid, haematopoietic and related tissue	0.000	0.993	0.007
C96.6 Unifocal Langerhans-cell histiocytosis	0.000	0.993	0.007
C96.5 Multifocal and unisystemic Langerhans-cell histiocytosis	0.000	0.993	0.007
C96.4 Sarcoma of dendritic cells (accessory cells)	0.000	0.993	0.007
C96.3 True histiocytic lymphoma	0.000	0.993	0.007
C96.2 Malignant mast cell tumour	0.000	0.993	0.007
C96.1 Malignant histiocytosis	0.000	0.993	0.007
C96.0 Letterer-Siwe disease	0.000	0.993	0.007
E51.9 Thiamine deficiency, unspecified	0.000	0.993	0.007
E51.8 Other manifestations of thiamine deficiency	0.000	0.993	0.007
E51.1 Beriberi	0.000	0.993	0.007
K40.2 Bilateral inguinal hernia, without obstruction or gangrene	0.000	0.993	0.007
K40 Inguinal hernia	0.000	0.993	0.007
E07.9 Disorder of thyroid, unspecified	0.007	0.993	0.000
E35 Disorders of endocrine glands in diseases classified elsewhere	0.000	0.993	0.007
E32 Diseases of thymus	0.000	0.993	0.007
E30 Disorders of puberty, not elsewhere classified	0.000	0.993	0.007
A41.1 Septicaemia due to other specified staphylococcus	0.000	0.993	0.007
C81.9 Hodgkin's disease, unspecified	0.000	0.993	0.007
E21.5 Disorder of parathyroid gland, unspecified	0.000	0.993	0.006
E66 Obesity	0.005	0.993	0.001
E20 Hypoparathyroidism	0.000	0.993	0.006
C86.6 Primary cutaneous CD30-positive T-cell proliferations	0.000	0.993	0.006
C86.4 Blastic NK-cell lymphoma	0.000	0.993	0.006
C86.3 Subcutaneous panniculitis-like T-cell lymphoma	0.000	0.993	0.006
C86.2 Enteropathy-type (intestinal) T-cell lymphoma	0.000	0.993	0.006
C86.1 Hepatosplenic T-cell lymphoma	0.000	0.993	0.006
C86.0 Extranodal NK/T-cell lymphoma, nasal type	0.000	0.993	0.006
E61.2 Magnesium deficiency	0.000	0.993	0.006
E61.1 Iron deficiency	0.000	0.994	0.006
C88.4 Extranodal marginal zone B-cell lymphoma of mucosa-associated lymphoid tissue [MALT-lymphoma]	0.000	0.994	0.006
E66.8 Other obesity	0.006	0.994	0.000
E25 Adrenogenital disorders	0.000	0.994	0.006
C88.9 Malignant immunoproliferative disease, unspecified	0.000	0.994	0.006
C88.7 Other malignant immunoproliferative diseases	0.000	0.994	0.006
C88.3 Immunoproliferative small intestinal disease	0.000	0.994	0.006
C88.2 Gamma heavy chain disease	0.000	0.994	0.006
C88.1 Alpha heavy chain disease	0.000	0.994	0.006
A44 Bartonellosis	0.000	0.994	0.006
A43 Nocardiosis	0.000	0.994	0.006
A42 Actinomycosis	0.000	0.994	0.006
A37 Whooping cough	0.000	0.994	0.006
A36 Diphtheria	0.000	0.994	0.006
A32 Listeriosis	0.000	0.994	0.006
A30 Leprosy [Hansen's disease]	0.000	0.994	0.006
A38 Scarlet fever	0.000	0.994	0.006
A35 Other tetanus	0.000	0.994	0.006
A34 Obstetrical tetanus	0.000	0.994	0.006
A33 Tetanus neonatorum	0.000	0.994	0.006
E21.4 Other specified disorders of parathyroid gland	0.000	0.994	0.006
A40.0 Septicaemia due to streptococcus, group A	0.000	0.994	0.006
K86.8 Other specified diseases of pancreas	0.000	0.994	0.006
C92.7 Other myeloid leukaemia	0.000	0.994	0.006
K86 Other diseases of pancreas	0.000	0.994	0.006
A31 Infection due to other mycobacteria	0.000	0.994	0.006
J31.0 Chronic rhinitis	0.000	0.994	0.006
E31 Polyglandular dysfunction	0.000	0.994	0.006
A41.2 Septicaemia due to unspecified staphylococcus	0.000	0.994	0.006
K40-K46 Hernia	0.000	0.994	0.006
K86.1 Other chronic pancreatitis	0.000	0.994	0.006
O47.1 False labour at or after 37 completed weeks of gestation	0.000	0.994	0.006
A41.8 Other specified septicaemia	0.000	0.994	0.006
C95.7 Other leukaemia of unspecified cell type	0.000	0.994	0.006
C95.2 Subacute leukaemia of unspecified cell type	0.000	0.994	0.006
C95.1 Chronic leukaemia of unspecified cell type	0.000	0.994	0.006
E34.5 Androgen resistance syndrome	0.000	0.994	0.006
E34.4 Constitutional tall stature	0.000	0.994	0.006
E34.3 Short stature, not elsewhere classified	0.000	0.994	0.006
E34.2 Ectopic hormone secretion, not elsewhere classified	0.000	0.994	0.006
E34.1 Other hypersecretion of intestinal hormones	0.000	0.994	0.006
C86.5 Angioimmunoblastic T-cell lymphoma	0.000	0.994	0.006
C92.9 Myeloid leukaemia, unspecified	0.000	0.994	0.006
C92.8 Acute myeloid leukaemia with multilineage dysplasia	0.000	0.994	0.006
C92.6 Acute myeloid leukaemia with 11q23-abnormality	0.000	0.994	0.006
C92.5 Acute myelomonocytic leukaemia	0.000	0.994	0.006
C92.3 Myeloid sarcoma	0.000	0.994	0.006
C92.2 Subacute myeloid leukaemia	0.000	0.994	0.006
E66.2 Extreme obesity with alveolar hypoventilation	0.005	0.994	0.001
E24.9 Cushing's syndrome, unspecified	0.000	0.994	0.006
A40.9 Streptococcal septicaemia, unspecified	0.000	0.994	0.006
K86.0 Alcohol-induced chronic pancreatitis	0.000	0.994	0.006
C84 Peripheral and cutaneous T-cell lymphomas	0.000	0.994	0.005
E24.0 Pituitary-dependent Cushing's disease	0.000	0.994	0.006
E22 Hyperfunction of pituitary gland	0.000	0.994	0.006
A40.1 Septicaemia due to streptococcus, group B	0.000	0.994	0.006
E53.1 Pyridoxine deficiency	0.000	0.994	0.005
E53.0 Riboflavin deficiency	0.000	0.994	0.005
E26 Hyperaldosteronism	0.000	0.994	0.005
A40.3 Septicaemia due to Streptococcus pneumoniae	0.000	0.994	0.005
R60 Oedema, not elsewhere classified	0.000	0.994	0.006
A40.2 Septicaemia due to streptococcus, group D	0.000	0.994	0.005
C92.1 Chronic myeloid leukaemia	0.000	0.994	0.005
A39 Meningococcal infection	0.000	0.995	0.005
C88.0 Waldenstrom's macroglobulinaemia	0.000	0.995	0.005
E51.2 Wernicke's encephalopathy	0.001	0.995	0.005
C95.0 Acute leukaemia of unspecified cell type	0.000	0.995	0.005
E24.8 Other Cushing's syndrome	0.000	0.995	0.005
E24.4 Alcohol-induced pseudo-Cushing's syndrome	0.000	0.995	0.005
E24.3 Ectopic ACTH syndrome	0.000	0.995	0.005
E24.1 Nelson's syndrome	0.000	0.995	0.005
K40.0 Bilateral inguinal hernia, with obstruction, without gangrene	0.000	0.995	0.005
C92.4 Acute promyelocytic leukaemia	0.000	0.995	0.005
K40.4 Unilateral or unspecified inguinal hernia, with gangrene	0.000	0.995	0.005
K40.1 Bilateral inguinal hernia, with gangrene	0.000	0.995	0.005
A48 Other bacterial diseases, not elsewhere classified	0.000	0.995	0.005
A40.8 Other streptococcal septicaemia	0.000	0.995	0.005
H36.0 Diabetic retinopathy	0.000	0.995	0.005
A49.9 Bacterial infection, unspecified	0.000	0.995	0.005
E30.9 Disorder of puberty, unspecified	0.000	0.995	0.005
E30.8 Other disorders of puberty	0.000	0.995	0.005
E30.1 Precocious puberty	0.000	0.995	0.005
E30.0 Delayed puberty	0.000	0.995	0.005
E32.9 Disease of thymus, unspecified	0.000	0.995	0.005
E32.8 Other diseases of thymus	0.000	0.995	0.005
E32.1 Abscess of thymus	0.000	0.995	0.005
E32.0 Persistent hyperplasia of thymus	0.000	0.995	0.005
E35.8 Disorders of other endocrine glands in diseases classified elsewhere	0.000	0.995	0.005

This table lists the top 500 terms ordered by p(effect).

The full results table can be downloaded from this page.

The TreeWAS Database is the result of research conducted at the Oxford Big Data Institute at the University of Oxford.

This research has been conducted using the UK Biobank Resource (application number 10625). This work uses data provided by patients and collected by the NHS as part of their care and support.

This research has been conducted with the support of the Wellcome Trust (100956/Z/13/Z and 090532/Z/09/Z and 100308/Z/12/Z), the Danish National Research Foundation, Takeda, the Medical Research Council (MC_UU_12010/3), the Oak Foundation (OCAY-15-520), the National Institute for Health Research (NIHR) Oxford Biomedical Research Centre (BRC), the Wellcome Trust/Royal Society (204290/Z/16/Z) and the Li Ka Shing Foundation.

Variant-specific associations